Skip to main content

What the FDA labels say about taking them together

Artemether/lumefantrine and disopyramide

Artemether/lumefantrine's FDA label of March 26, 2026 names disopyramide in its warnings and precautions section; the disopyramide label PlainMeds reads does not name artemether/lumefantrine. The artemether/lumefantrine label: “Receiving other medications that prolong the QT interval, such as Class IA, or Class III (amiodarone, sotalol) antiarrhythmic agents; antipsychotics (pimozide, ziprasidone); antidepressants; certain antibiotics.”

Check it at the source: the artemether/lumefantrine FDA label on DailyMed (effective March 26, 2026, Novartis Pharmaceuticals Corporation); the disopyramide FDA label on DailyMed (effective August 24, 2026, Pfizer Laboratories Div Pfizer Inc).

What does the artemether/lumefantrine label say about disopyramide?

Artemether/lumefantrine label, warnings and precautions

Receiving other medications that prolong the QT interval, such as Class IA (quinidine, procainamide, disopyramide), or Class III (amiodarone, sotalol) antiarrhythmic agents; antipsychotics (pimozide, ziprasidone); antidepressants; certain antibiotics (macrolide antibiotics, fluoroquinolone antibiotics, imidazole, and triazole antifungal agents) [see Clinical Pharmacology (12.6)].

Source: FDA drug label (COARTEM), Novartis Pharmaceuticals Corporation, effective March 26, 2026 (SPL set 7866ec19-dfac-47d4-a53f-511a12643cbf), via openFDA; the full label on DailyMed

What does the disopyramide label say about artemether/lumefantrine?

Disopyramide's label (effective August 24, 2026) does not name artemether/lumefantrine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Norpace), Pfizer Laboratories Div Pfizer Inc, effective August 24, 2026 (SPL set e2aa1642-d262-4520-bc6a-9fd3ad795677), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Artemether/lumefantrine generic labelers
2Disopyramide generic labelers
Artemether/lumefantrineDisopyramide
Labeled forn/an/a
Boxed warningNoYes
Pharmacy cost (NADAC)$5.36 per tablet Coartem tablets$0.801 per capsule 100 mg capsule
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?